Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by woundedkneeon Feb 24, 2021 3:16pm
88 Views
Post# 32649468

RE:RE:A bad smell ensues again.

RE:RE:A bad smell ensues again.
In actual fact, by calling Graham all of these names you are trying to distract from the facts. And Graham does indeed state facts. So you deny the facts by calling him names which you hope will hide the financial short comings of this company. I am sure those that bought near the highs instead of selling are probably the name callers. Lots of stocks climb to tremendous heights on sheer speculation, but only for so long. The hardest thing in the market is knowing when to sell. I am not giving up on this company. I made a ton of money from 18 to 50 cents and got out near the highs. As stated before, I am now taking a breather and will get back in when I see revenue. I really believe in this company and am ready to invest heavily again. Keep up the good work Graham. And good luck to all.
<< Previous
Bullboard Posts
Next >>